Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Gross Profit (2017 - 2025)

Historic Gross Profit for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $97.7 million.

  • Organogenesis Holdings' Gross Profit rose 1049.43% to $97.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.3 million, marking a year-over-year decrease of 1000.76%. This contributed to the annual value of $366.3 million for FY2024, which is 1213.59% up from last year.
  • Organogenesis Holdings' Gross Profit amounted to $97.7 million in Q3 2025, which was up 1049.43% from $52.1 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Gross Profit peaked at $101.0 million during Q2 2024, and registered a low of $52.1 million during Q2 2025.
  • For the 5-year period, Organogenesis Holdings' Gross Profit averaged around $84.5 million, with its median value being $88.4 million (2024).
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 9063.74% in 2021, then plummeted by 4846.99% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Gross Profit stood at $95.3 million in 2021, then decreased by 7.2% to $88.4 million in 2022, then fell by 18.69% to $71.9 million in 2023, then soared by 33.0% to $95.6 million in 2024, then rose by 2.15% to $97.7 million in 2025.
  • Its Gross Profit was $97.7 million in Q3 2025, compared to $52.1 million in Q2 2025 and $63.0 million in Q1 2025.